257 related articles for article (PubMed ID: 31699629)
1. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?
Sneeboer MAM; van der Doef T; Litjens M; Psy NBB; Melief J; Hol EM; Kahn RS; de Witte LD
Schizophr Res; 2020 Jan; 215():167-172. PubMed ID: 31699629
[TBL] [Abstract][Full Text] [Related]
2. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
Notter T; Coughlin JM; Gschwind T; Weber-Stadlbauer U; Wang Y; Kassiou M; Vernon AC; Benke D; Pomper MG; Sawa A; Meyer U
Mol Psychiatry; 2018 Feb; 23(2):323-334. PubMed ID: 28093569
[TBL] [Abstract][Full Text] [Related]
3. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands.
Owen DR; Matthews PM
Int Rev Neurobiol; 2011; 101():19-39. PubMed ID: 22050847
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.
Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R
Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066
[TBL] [Abstract][Full Text] [Related]
5. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.
Owen DR; Narayan N; Wells L; Healy L; Smyth E; Rabiner EA; Galloway D; Williams JB; Lehr J; Mandhair H; Peferoen LA; Taylor PC; Amor S; Antel JP; Matthews PM; Moore CS
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2679-2690. PubMed ID: 28530125
[TBL] [Abstract][Full Text] [Related]
8. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
[TBL] [Abstract][Full Text] [Related]
10. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
[TBL] [Abstract][Full Text] [Related]
11. Effect of overnight smoking abstinence on a marker for microglial activation: a [
Brody AL; Gehlbach D; Garcia LY; Enoki R; Hoh C; Vera D; Kotta KK; London ED; Okita K; Nurmi EL; Seaman LC; Mandelkern MA
Psychopharmacology (Berl); 2018 Dec; 235(12):3525-3534. PubMed ID: 30343364
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
[TBL] [Abstract][Full Text] [Related]
13. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
14. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
15. Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.
Karlstetter M; Nothdurfter C; Aslanidis A; Moeller K; Horn F; Scholz R; Neumann H; Weber BH; Rupprecht R; Langmann T
J Neuroinflammation; 2014 Jan; 11():3. PubMed ID: 24397957
[TBL] [Abstract][Full Text] [Related]
16. Microglial positron emission tomography (PET) imaging in epilepsy: Applications, opportunities and pitfalls.
Scott G; Mahmud M; Owen DR; Johnson MR
Seizure; 2017 Jan; 44():42-47. PubMed ID: 27884611
[TBL] [Abstract][Full Text] [Related]
17. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.
Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE
Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810
[TBL] [Abstract][Full Text] [Related]
18. Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study.
Holmes SE; Hinz R; Conen S; Gregory CJ; Matthews JC; Anton-Rodriguez JM; Gerhard A; Talbot PS
Biol Psychiatry; 2018 Jan; 83(1):61-69. PubMed ID: 28939116
[TBL] [Abstract][Full Text] [Related]
19. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis.
Conen S; Gregory CJ; Hinz R; Smallman R; Corsi-Zuelli F; Deakin B; Talbot PS
Mol Psychiatry; 2021 Sep; 26(9):5398-5406. PubMed ID: 32606376
[TBL] [Abstract][Full Text] [Related]
20. Increased microglial activation in patients with Parkinson disease using [
Lavisse S; Goutal S; Wimberley C; Tonietto M; Bottlaender M; Gervais P; Kuhnast B; Peyronneau MA; Barret O; Lagarde J; Sarazin M; Hantraye P; Thiriez C; Remy P
Parkinsonism Relat Disord; 2021 Jan; 82():29-36. PubMed ID: 33242662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
